| 000 | 01516 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516062522.0 | ||
| 264 | 0 | _c20120426 | |
| 008 | 201204s 0 0 eng d | ||
| 022 | _a1347-5215 | ||
| 024 | 7 |
_a10.1248/bpb.34.1765 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIwata, Kazufumi | |
| 245 | 0 | 0 |
_aThe relationship between treatment time of gemcitabine and development of hematologic toxicity in cancer patients. _h[electronic resource] |
| 260 |
_bBiological & pharmaceutical bulletin _c2011 |
||
| 300 |
_a1765-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCircadian Rhythm |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aAizawa, Keiji | |
| 700 | 1 | _aSakai, Saori | |
| 700 | 1 | _aJingami, Sachiko | |
| 700 | 1 | _aFukunaga, Eiko | |
| 700 | 1 | _aYoshida, Minoru | |
| 700 | 1 | _aHamada, Akinobu | |
| 700 | 1 | _aSaito, Hideyuki | |
| 773 | 0 |
_tBiological & pharmaceutical bulletin _gvol. 34 _gno. 11 _gp. 1765-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1248/bpb.34.1765 _zAvailable from publisher's website |
| 999 |
_c21271532 _d21271532 |
||